Catabasis Pharmaceuticals, Inc. Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer

Published: Sep 08, 2011

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a biopharmaceutical company leveraging the therapeutic potential of omega-3 fatty acids and other well-characterized compounds to create dual action medicines for the treatment of inflammatory and metabolic diseases, today announced the appointment of Joanne M. Donovan, M.D., Ph.D., to the position of chief medical officer. In this new role, Dr. Donovan will oversee Catabasis’ clinical development and clinical regulatory strategy as the company prepares to begin human clinical trials of its lead program in type 2 diabetes.

Back to news